3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Ovarian Neoplasms
12
Small Cell Lung Carcinoma
8
Carcinoma, Ovarian Epithelial
5
Uterine Cervical Neoplasms
4
Neoplasms
4
Neuroblastoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Fallopian Tube Neoplasms
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocytopenia
1
Solid Tumors
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
SCLC, Extensive Stage
1
Recurrence
1
Radiation Injuries
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Peritoneal Neoplasms
1
Myoepithelioma
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Liposarcoma, Myxoid
1
Interventions
pembrolizumab
4
Injections
3
Nivolumab
2
Docetaxel
2
taxane
1
pazopanib
1
palbociclib
1
lenvatinib
1
demplatin pegraglumer
1
cobimetinib
1
birinapant
1
Topotecan
1
Tablets
1
ODM-207
1
Infusions, Intravenous
1
HLA-A*24:02 antigen
1
Gemcitabine
1
E-3810
1
CB-839
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Solid Tumors
×
Topotecan
×
Clear all
NCT02303028
2022-06-28
TOPAZ
The Hospital for Sick Children
Phase 1/2
Completed
30 enrolled